• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阿片类药物在中枢神经系统中诱导的细胞耐受性。

Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System.

作者信息

Adhikary Sweta, Williams John T

机构信息

Vollum Institute, Oregon Health & Science University, Portland, OR, United States.

出版信息

Front Syst Neurosci. 2022 Jun 28;16:937126. doi: 10.3389/fnsys.2022.937126. eCollection 2022.

DOI:10.3389/fnsys.2022.937126
PMID:35837149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9273719/
Abstract

Opioids are powerful analgesics that elicit acute antinociceptive effects through their action the mu opioid receptor (MOR). However opioids are ineffective for chronic pain management, in part because continuous activation of MORs induces adaptive changes at the receptor level and downstream signaling molecules. These adaptations include a decrease in receptor-effector coupling and changes to second messenger systems that can counteract the persistent activation of MORs by opioid agonists. Homeostatic regulation of MORs and downstream signaling cascades are viewed as precursors to developing tolerance. However, despite numerous studies identifying crucial mechanisms that contribute to opioid tolerance, no single regulatory mechanism that governs tolerance in at the cellular and systems level has been identified. Opioid tolerance is a multifaceted process that involves both individual neurons that contain MORs and neuronal circuits that undergo adaptations following continuous MOR activation. The most proximal event is the agonist/receptor interaction leading to acute cellular actions. This review discusses our understanding of mechanisms that mediate cellular tolerance after chronic opioid treatment that, in part, is mediated by agonist/receptor interaction acutely.

摘要

阿片类药物是强效镇痛药,通过作用于μ阿片受体(MOR)产生急性抗伤害感受作用。然而,阿片类药物对慢性疼痛管理无效,部分原因是MOR的持续激活会在受体水平和下游信号分子上诱导适应性变化。这些适应性变化包括受体 - 效应器偶联的减少以及第二信使系统的改变,这些改变可以抵消阿片类激动剂对MOR的持续激活。MOR和下游信号级联的稳态调节被视为产生耐受性的前兆。然而,尽管有大量研究确定了导致阿片类耐受性的关键机制,但尚未确定在细胞和系统水平上控制耐受性的单一调节机制。阿片类耐受性是一个多方面的过程,涉及含有MOR的单个神经元以及在MOR持续激活后发生适应性变化的神经回路。最直接的事件是激动剂/受体相互作用导致急性细胞作用。本综述讨论了我们对慢性阿片类药物治疗后介导细胞耐受性机制的理解,部分是由激动剂/受体急性相互作用介导的。

相似文献

1
Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System.慢性阿片类药物在中枢神经系统中诱导的细胞耐受性。
Front Syst Neurosci. 2022 Jun 28;16:937126. doi: 10.3389/fnsys.2022.937126. eCollection 2022.
2
Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.在躯体μ-阿片受体的多个效应器上观察到的差异脱敏是阿片类激动剂介导的阿黑皮素原神经元活动持续抑制的基础。
J Neurosci. 2017 Sep 6;37(36):8667-8677. doi: 10.1523/JNEUROSCI.1030-17.2017. Epub 2017 Aug 7.
3
μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.初级感觉神经元中的 μ-阿片受体对于阿片类药物在急性和炎症性疼痛以及阿片类药物引起的痛觉过敏中的镇痛作用是必不可少的。
J Physiol. 2019 Mar;597(6):1661-1675. doi: 10.1113/JP277428. Epub 2019 Jan 16.
4
Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.吗啡通过将Gα亚基持续转移至RGSZ2蛋白,诱导神经元μ-阿片受体的内吞作用。
Mol Pain. 2007 Jul 17;3:19. doi: 10.1186/1744-8069-3-19.
5
β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.β-抑制蛋白2基因敲除可防止细胞μ-阿片受体耐受性的发展,但不影响单个中脑导水管周围灰质神经元中与阿片类药物戒断相关的适应性变化。
Br J Pharmacol. 2015 Jan;172(2):492-500. doi: 10.1111/bph.12673. Epub 2014 Jul 1.
6
On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance.外周感觉和肠道 μ 阿片受体的作用:外周镇痛和耐受。
Molecules. 2020 May 26;25(11):2473. doi: 10.3390/molecules25112473.
7
Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery?预防阿片类药物耐受性的药理学方法是否针对同一调节机制中的不同要素?
Curr Drug Abuse Rev. 2008 Jun;1(2):222-38. doi: 10.2174/1874473710801020222.
8
Selective up-regulation of functional mu-opioid receptor splice variants by chronic opioids.慢性阿片类药物对功能性μ-阿片受体剪接变体的选择性上调。
J Neurochem. 2016 Mar;136(6):1119-1130. doi: 10.1111/jnc.13519. Epub 2016 Jan 20.
9
Chronic morphine induces adaptations in opioid receptor signaling in a thalamo-cortico-striatal circuit that are projection-dependent, sex-specific and regulated by mu opioid receptor phosphorylation.慢性吗啡会在丘脑-皮质-纹状体回路中诱导阿片受体信号传导的适应性变化,这些变化依赖于投射、具有性别特异性且受μ阿片受体磷酸化调节。
bioRxiv. 2023 Feb 14:2023.02.13.528057. doi: 10.1101/2023.02.13.528057.
10
Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor- Signaling, Not -Opioid Receptor Internalization.脊髓阿片类药物耐受取决于血小板衍生生长因子受体信号,而不是阿片受体内化。
Mol Pharmacol. 2020 Oct;98(4):487-496. doi: 10.1124/mol.120.119552. Epub 2020 Jul 28.

引用本文的文献

1
Molecular and cellular basis of mu-opioid receptor signaling: mechanisms underlying tolerance and dependence development.μ-阿片受体信号传导的分子和细胞基础:耐受性和依赖性发展的潜在机制。
Front Neurosci. 2025 Jun 24;19:1597922. doi: 10.3389/fnins.2025.1597922. eCollection 2025.
2
Mu-opioid receptor activation potentiates excitatory transmission at the habenulo-peduncular synapse.μ-阿片受体激活增强缰核-脚间核突触处的兴奋性传递。
Cell Rep. 2025 Jul 22;44(7):115874. doi: 10.1016/j.celrep.2025.115874. Epub 2025 Jun 19.
3
Persistent Transcriptome Alterations in Zebrafish Embryos After Discontinued Opioid Exposure.阿片类药物暴露停止后斑马鱼胚胎中持续的转录组改变。
Int J Mol Sci. 2025 May 19;26(10):4840. doi: 10.3390/ijms26104840.
4
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.丁丙诺啡的药效学:理解丁丙诺啡临床益处的桥梁。
Drugs. 2025 Feb;85(2):215-230. doi: 10.1007/s40265-024-02128-y. Epub 2025 Jan 28.
5
FLT3 signaling inhibition abrogates opioid tolerance and hyperalgesia while preserving analgesia.FLT3 信号抑制可消除阿片耐受和痛觉过敏,同时保留镇痛作用。
Nat Commun. 2024 Nov 7;15(1):9633. doi: 10.1038/s41467-024-54054-y.
6
The influence of drug class on reward in substance use disorders.药物种类对物质使用障碍中奖励的影响。
Pharmacol Biochem Behav. 2024 Jul;240:173771. doi: 10.1016/j.pbb.2024.173771. Epub 2024 Apr 24.
7
Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study.低剂量氯胺酮输注以促进阿片类药物使用障碍患者慢性非癌性疼痛中阿片类药物的减量:一项历史性队列研究。
Reg Anesth Pain Med. 2025 May 6;50(5):421-428. doi: 10.1136/rapm-2023-105035.
8
Relationship between opioid cross-tolerance during buprenorphine stabilization and return to opioid use during buprenorphine dose tapering.丁丙诺啡稳定治疗期间阿片类药物交叉耐受与丁丙诺啡剂量递减期间阿片类药物使用复吸的关系。
Psychopharmacology (Berl). 2024 Jun;241(6):1151-1160. doi: 10.1007/s00213-024-06549-1. Epub 2024 Feb 8.
9
Chronic Morphine Leaves a Durable Fingerprint on Whole-Brain Functional Connectivity.慢性吗啡在全脑功能连接上留下持久印记。
Biol Psychiatry. 2024 Nov 1;96(9):708-716. doi: 10.1016/j.biopsych.2023.12.007. Epub 2023 Dec 15.
10
Exposure to Sedation and Analgesia Medications: Short-term Cognitive Outcomes in Pediatric Critical Care Survivors With Acquired Brain Injury.镇静和镇痛药物暴露:伴有获得性脑损伤的儿科危重病幸存者的短期认知结局。
J Intensive Care Med. 2024 Apr;39(4):374-386. doi: 10.1177/08850666231210261. Epub 2023 Oct 26.

本文引用的文献

1
Agonist-Specific Regulation of G Protein-Coupled Receptors after Chronic Opioid Treatment.慢性阿片类药物治疗后 G 蛋白偶联受体的激动剂特异性调节。
Mol Pharmacol. 2022 May;101(5):300-308. doi: 10.1124/molpharm.121.000453. Epub 2022 Feb 22.
2
Mu Opioid Receptors Acutely Regulate Adenosine Signaling in Striatal Glutamate Afferents.μ 阿片受体在纹状体谷氨酸传入中急性调节腺苷信号。
J Neurosci. 2022 Mar 23;42(12):2404-2417. doi: 10.1523/JNEUROSCI.1039-21.2022. Epub 2022 Jan 28.
3
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review.阿片类镇痛与阿片类药物所致不良反应:综述
Pharmaceuticals (Basel). 2021 Oct 27;14(11):1091. doi: 10.3390/ph14111091.
4
Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists.低内在效能本身并不能解释新型阿片类激动剂改善的副作用谱。
Biochemistry. 2022 Sep 20;61(18):1923-1935. doi: 10.1021/acs.biochem.1c00466. Epub 2021 Sep 1.
5
Divergent profiles of fentanyl withdrawal and associated pain in mice and rats.在小鼠和大鼠中,芬太尼戒断和相关疼痛的表现不同。
Pharmacol Biochem Behav. 2021 Jan;200:173077. doi: 10.1016/j.pbb.2020.173077. Epub 2020 Dec 11.
6
Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.慢性吗啡处理破坏 GPCR 激酶依赖的快速脱敏。
Mol Pharmacol. 2020 Oct;98(4):497-507. doi: 10.1124/mol.119.119362. Epub 2020 May 3.
7
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.对G蛋白激活的内在效力较低可以解释新型阿片类激动剂改善的副作用情况。
Sci Signal. 2020 Mar 31;13(625):eaaz3140. doi: 10.1126/scisignal.aaz3140.
8
Recent Progress in Opioid Research from an Electrophysiological Perspective.从电生理学角度看阿片类药物研究的最新进展。
Mol Pharmacol. 2020 Oct;98(4):401-409. doi: 10.1124/mol.119.119040. Epub 2020 Mar 20.
9
A Discrete Presynaptic Vesicle Cycle for Neuromodulator Receptors.神经调质受体的离散突触小泡循环。
Neuron. 2020 Feb 19;105(4):663-677.e8. doi: 10.1016/j.neuron.2019.11.016. Epub 2019 Dec 11.
10
Synapse-specific opioid modulation of thalamo-cortico-striatal circuits.突触特异性阿片类调制丘脑皮质纹状体回路。
Elife. 2019 May 17;8:e45146. doi: 10.7554/eLife.45146.